Behcet's syndrome pathophysiology and potential therapeutic targets

被引:51
|
作者
Emmi, Giacomo [1 ]
Silvestri, Elena [1 ,2 ,3 ]
Squatrito, Danilo [2 ,3 ]
D'Elios, Mario Milco [1 ,2 ,3 ]
Ciucciarelli, Lucia [1 ]
Prisco, Domenico [1 ,2 ,3 ]
Emmi, Lorenzo [2 ,3 ]
机构
[1] Univ Florence, Dept Expt & Clin Med, I-50134 Florence, Italy
[2] AOU Careggi, SOD Patol Med, Ctr Autoimmune Syst Dis, Behcet Ctr, Florence, Italy
[3] AOU Careggi, Lupus Clin, Florence, Italy
关键词
Behcet syndrome pathophysiology; Behcet treatment; Biologic therapy; Anti-TNF-alpha; IL-1 blocking agents; GENOME-WIDE ASSOCIATION; TUMOR-NECROSIS-FACTOR; V-GAMMA-9/V-DELTA-2; T-LYMPHOCYTES; FAMILIAL MEDITERRANEAN FEVER; INTERFERON ALPHA-2A; STREPTOCOCCUS-SANGUIS; DOUBLE-BLIND; TNF FAMILY; DISEASE; UVEITIS;
D O I
10.1007/s11739-013-1036-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Behcet syndrome is a systemic inflammatory disorder characterized by multiorgan involvement such as oral and genital ulcers, uveitis, skin lesions as well as by less frequent, but often more severe, central nervous system and vascular manifestations. The pathogenetic mechanisms are still incompletely known; however the interaction between a specific genetic background and environmental or infectious factors certainly contributes to the immune dysregulation that characterizes this disease. The discovery of new immunological pathways in Behcet syndrome pathogenesis may help us to set up new treatments. In this review, we will focus our attention on the possible mechanisms underlying Behcet syndrome pathogenesis and their potential role as novel therapeutic targets.
引用
收藏
页码:257 / 265
页数:9
相关论文
共 50 条
  • [11] Management of Behcet's syndrome
    Karadag, Omer
    Bolek, Ertugrul Cagri
    RHEUMATOLOGY, 2020, 59 : 108 - 117
  • [12] Management of Behcet's syndrome
    Ozguler, Yesim
    Hatemi, Gulen
    CURRENT OPINION IN RHEUMATOLOGY, 2016, 28 (01) : 45 - 50
  • [13] Headache in Behcet's Syndrome: Review of Literature and NYU Behcet's Syndrome Center Experience
    Vishwanath, Vijay
    Wong, Ericka
    Crystal, Sara C.
    Robbins, Matthew S.
    Filopoulos, Maria
    Lipton, Richard B.
    Yazici, Yusuf
    Kister, Ilya
    CURRENT PAIN AND HEADACHE REPORTS, 2014, 18 (09)
  • [14] Clinical heterogeneity of ocular Behcet's syndrome versus intestinal Behcet's syndrome: a cross-sectional study from Shanghai Behcet's syndrome database
    Hou, Cheng-Cheng
    Luo, Dan
    Bao, Hua-Fang
    Ye, Jing-Fen
    Ma, Hai-Fen
    Shen, Yan
    Zou, Jun
    Guan, Jian-Long
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
  • [15] Critical Illness and the Frailty Syndrome: Mechanisms and Potential Therapeutic Targets
    Paul, Jonathan A.
    Whittington, Robert A.
    Baldwin, Matthew R.
    ANESTHESIA AND ANALGESIA, 2020, 130 (06): : 1545 - 1555
  • [16] Empiricism in managing Behcet's syndrome
    Yazici, H.
    Hatemi, G.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (03) : S7 - S9
  • [17] Diabetic Kidney Disease: Pathophysiology and Therapeutic Targets
    Toth-Manikowski, Stephanie
    Atta, Mohamed G.
    JOURNAL OF DIABETES RESEARCH, 2015, 2015
  • [18] Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy
    Alsahhar, Jamil S.
    Rahimi, Robert S.
    CURRENT OPINION IN GASTROENTEROLOGY, 2019, 35 (03) : 145 - 154
  • [19] Sjogren's syndrome: Old and new therapeutic targets
    Mavragani, Clio P.
    Moutsopoulos, Haralampos M.
    JOURNAL OF AUTOIMMUNITY, 2020, 110
  • [20] Are Lysosomes Potential Therapeutic Targets for Parkinson's Disease?
    Petese, Alessandro
    Cesaroni, Valentina
    Cerri, Silvia
    Blandini, Fabio
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2022, 21 (08) : 642 - 655